Tumor-Targeted Delivery of CRISPR/Cas9 Systems Mediated by Extracellular Vesicles

CRISPR/Cas9 gene-editing technology can directly modify the genes that plays a vital role in cancer. Currently, it has been increasingly being precisely applied in cancer treatment. In vivo safe and effective delivery is still a problem that has not been solved yet. It is to be solved in current delivery system for viral vectors. For examples, they are highly immunogenic and carry the risk of random genomic integration. Synthetic non-viral vectors have poor circulatory stability and insufficient tumor accumulation. Therefore, it is difficult to achieve a good balance between safety and delivery efficiency. Extracellular vesicles (EVs) are natural, membrane-bound carriers that have low immunogenicity, can protect the contents of cells from damage in a living organism and also function as tumour-homing agents. The main ways to load CRISPR/Cas9 into EVs, some strategies for targeted modification, and problems that still need to be solved in the future will be introduced in this paper.

Authors

Institutions

Publication Details

Journal
Theoretical and Natural Science
Published
2026-11-17
DOI
https://doi.org/10.54254/2753-8818/2027.mb39079
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tumor-Targeted Delivery of CRISPR/Cas9 Systems Mediated by Extracellular Vesicles

Zonglin Li
Theoretical and Natural Science
Extracellular vesicles in disease
article

Tumor-Targeted Delivery of CRISPR/Cas9 Systems Mediated by Extracellular Vesicles

Zonglin Li
article en

Abstract

CRISPR/Cas9 gene-editing technology can directly modify the genes that plays a vital role in cancer. Currently, it has been increasingly being precisely applied in cancer treatment. In vivo safe and effective delivery is still a problem that has not been solved yet. It is to be solved in current delivery system for viral vectors. For examples, they are highly immunogenic and carry the risk of random genomic integration. Synthetic non-viral vectors have poor circulatory stability and insufficient tumor accumulation. Therefore, it is difficult to achieve a good balance between safety and delivery efficiency. Extracellular vesicles (EVs) are natural, membrane-bound carriers that have low immunogenicity, can protect the contents of cells from damage in a living organism and also function as tumour-homing agents. The main ways to load CRISPR/Cas9 into EVs, some strategies for targeted modification, and problems that still need to be solved in the future will be introduced in this paper.

Theoretical and Natural ScienceVol. 202(1)
Xi'an Jiaotong University (CN)
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon